Interleukins 15 and 12 in combination expand the selective loss of natural killer T cells in HIV infection in vitro

Clinical and Experimental Medicine

Volumn 15, Issue 2, 2015, Pages 205-213

  Parasa, Venkata Ramanarao ^a   Selvaraj, Anbalagan ^a   Sikhamani, Rajasekaran ^b   Raja, Alamelu ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b Government Hospital of Thoracic Medicine   (India)

Author keywords

HIV; IL 12; IL 15; NKT cells; TB

Indexed keywords

IL15 PROTEIN, HUMAN; INTERLEUKIN 12; INTERLEUKIN 15; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1 PROTEIN, HUMAN;

ADULT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; NATURAL KILLER T CELL; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-12; INTERLEUKIN-15; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER T-CELLS; YOUNG ADULT;

EID: 84939895348     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-014-0278-5     Document Type: Article

References (40)

1. Behar SM, Porcelli SA (2007) CD1-restricted T cells in host defense to infectious diseases. Curr Top Microbiol Immunol 314:215–250
2. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS, Berzins SP, Smyth MJ, Godfrey DI (2008) Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4–NK1.1–NKT cell population. Proc Natl Acad Sci USA 105(32):11287–11292. doi:10.1073/pnas.0801631105
3. Gumperz JE, Miyake S, Yamamura T, Brenner MB (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195(5):625–636
4. Juno JA, Keynan Y, Fowke KR (2012) Invariant NKT cells: regulation and function during viral infection. PLoS Pathog 8(8):e1002838. doi:10.1371/journal.ppat.1002838
5. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297–336. doi:10.1146/annurev.immunol.25.022106.141711
6. Araki M, Miyake S, Yamamura T (2008) Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapy. Curr Med Chem 15(23):2337–2345
7. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M (1997) CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278(5343):1626–1629
8. Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306(5702):1786–1789. doi:10.1126/science.1103440
9. Christiansen D, Milland J, Mouhtouris E, Vaughan H, Pellicci DG, McConville MJ, Godfrey DI, Sandrin MS (2008) Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol 6(7):e172. doi:10.1371/journal.pbio.0060172
10. Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, Gadola SD, Hsu FF, Besra GS, Brenner MB (2011) Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 12(12):1202–1211. doi:10.1038/ni.2143
11. Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, Abrignani S (1998) Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 28(11):3448–3455
12. Ohteki T, MacDonald HR (1994) Major histocompatibility complex class I related molecules control the development of CD4+ 8- and CD4-8-subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J Exp Med 180(2):699–704
13. Lee PT, Benlagha K, Teyton L, Bendelac A (2002) Distinct functional lineages of human Vα24 natural killer T cells. J Exp Med 195(5):637–641
14. Motsinger A, Haas DW, Stanic AK, Van Kaer L, Joyce S, Unutmaz D (2002) CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection. J Exp Med 195(7):869–879
15. Sandberg JK, Fast NM, Palacios EH, Fennelly G, Dobroszycki J, Palumbo P, Wiznia A, Grant RM, Bhardwaj N, Rosenberg MG, Nixon DF (2002) Selective loss of innate CD4(+) Vα24 natural killer T cells in human immunodeficiency virus infection. J Virol 76(15):7528–7534
16. van der Vliet HJ, von Blomberg BM, Hazenberg MD, Nishi N, Otto SA, van Benthem BH, Prins M, Claessen FA, van den Eertwegh AJ, Giaccone G, Miedema F, Scheper RJ, Pinedo HM (2002) Selective decrease in circulating Vα24 + Vβ11 + NKT cells during HIV type 1 infection. J Immunol 168(3):1490–1495
17. Silveira H, Ordway D, Dockrell H, Jackson M, Ventura F (1997) Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection. Clin Exp Immunol 110(1):26–34
18. Ramana Rao PV, Rajasekaran S, Raja A (2008) Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection. AIDS Res Hum Retrovir 24(11):1435–1443
19. Ramana Rao PV, Rajasekaran S, Raja A (2010) Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis. J Interferon Cytokine Res 30(1):33–42. doi:10.1089/jir.2009.0018
20. RNTCP (2005) Revised National Tuberculosis Control Programme module for laboratory technicians. Ministry of Health and Family Welfare, New Delhi, India. http://www.tbcindia.nic.in/pdfs/Module%20for%20Laboratory%20Technician.pdf. Assessed on 7 Sept 2013
21. Brennan PJ, Brigl M, Brenner MB (2013) Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 13(2):101–117. doi:10.1038/nri3369
22. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114(10):1379–1388. doi:10.1172/JCI23594
23. Montoya CJ, Catano JC, Ramirez Z, Rugeles MT, Wilson SB, Landay AL (2008) Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol 127(1):1–6. doi:10.1016/j.clim.2007.12.006
24. Kee SJ, Kwon YS, Park YW, Cho YN, Lee SJ, Kim TJ, Lee SS, Jang HC, Shin MG, Shin JH, Suh SP, Ryang DW (2012) Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection. Infect Immun 80(6):2100–2108. doi:10.1128/IAI.06018-11
25. Snyder-Cappione JE, Nixon DF, Loo CP, Chapman JM, Meiklejohn DA, Melo FF, Costa PR, Sandberg JK, Rodrigues DS, Kallas EG (2007) Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J Infect Dis 195(9):1361–1364. doi:10.1086/513567
26. Carvalho KI, Bruno FR, Snyder-Cappione JE, Maeda SM, Tomimori J, Xavier MB, Haslett PA, Nixon DF, Kallas EG (2012) Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients. Immunology 136(1):96–102. doi:10.1111/j.1365-2567.2012.03563.x
27. Moll M, Kuylenstierna C, Gonzalez VD, Andersson SK, Bosnjak L, Sonnerborg A, Quigley MF, Sandberg JK (2009) Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection. Eur J Immunol 39(3):902–911. doi:10.1002/eji.200838780
28. Moll M, Snyder-Cappione J, Spotts G, Hecht FM, Sandberg JK, Nixon DF (2006) Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2. Blood 107(8):3081–3083. doi:10.1182/blood-2005-09-3636
29. Lin H, Nieda M, Nicol AJ (2004) Differential proliferative response of NKT cell subpopulations to in vitro stimulation in presence of different cytokines. Eur J Immunol 34(10):2664–2671. doi:10.1002/eji.200324834
30. Lind SM, Kuylenstierna C, Moll M, Jordö ED, Winqvist O, Lundeberg L, Karlsson MA, Linder MT, Johansson C, Scheynius A, Sandberg JK, Karlsson MC (2009) IL-18 skews the invariant NKT-cell population via autoreactive activation in atopic eczema. Eur J Immunol 39(8):2293–2301. doi:10.1002/eji.200839195
31. Molling JW, Moreno M, van der Vliet HJ, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, Bontkes HJ (2007) Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity. J Immunol Methods 322(1–2):70–81. doi:10.1016/j.jim.2007.02.002
32. Nishi N, van der Vliet HJ, Koezuka Y, von Blomberg BM, Scheper RJ, Pinedo HM, Giaccone G (2000) Synergistic effect of KRN7000 with interleukin-15, -7, and -2 on the expansion of human Vα24 + Vβ11 + T cells in vitro. Hum Immunol 61(4):357–365
33. van der Vliet HJ, Nishi N, Koezuka Y, von Blomberg BM, van den Eertwegh AJ, Porcelli SA, Pinedo HM, Scheper RJ, Giaccone G (2001) Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15. J Immunol Methods 247(1–2):61–72
34. Yao CY, Wang ZH, Jiang LN, Peng MY, Wang J, Li BQ (2010) IL-2 stimulated responses of CD3(+) CD56(+) NKT cells in pulmonary tuberculosis patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 26(9):884–886
35. Leite-De-Moraes MC, Hameg A, Arnould A, Machavoine F, Koezuka Y, Schneider E, Herbelin A, Dy M (1999) A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol 163(11):5871–5876
36. Kuylenstierna C, Bjorkstrom NK, Andersson SK, Sahlstrom P, Bosnjak L, Paquin-Proulx D, Malmberg KJ, Ljunggren HG, Moll M, Sandberg JK (2011) NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur J Immunol 41(7):1913–1923. doi:10.1002/eji.200940278
37. Apostolou I, Takahama Y, Belmant C, Kawano T, Huerre M, Marchal G, Cui J, Taniguchi M, Nakauchi H, Fournie JJ, Kourilsky P, Gachelin G (1999) Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 96(9):5141–5146
38. Kim CH, Johnston B, Butcher EC (2002) Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24 + Vβ11 + NKT cell subsets with distinct cytokine-producing capacity. Blood 100(1):11–16
39. Paquin-Proulx D, Santos BA, Carvalho KI, Toledo-Barros M, de Oliveira AKB, Kokron CM, Kalil J, Moll M, Kallas EG, Sandberg JK (2013) IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PLoS ONE 8(10):e75199. doi:10.1371/journal.pone.0075199PONE-D-13-22056
40. Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2(8):557–568